Australia markets closed

  • ALL ORDS

    7,000.60
    -67.30 (-0.95%)
     

  • AUD/USD

    0.7777
    -0.0001 (-0.01%)
     

  • ASX 200

    6,760.70
    -57.30 (-0.84%)
     

  • OIL

    60.67
    -0.61 (-1.00%)
     

  • GOLD

    1,708.60
    -7.20 (-0.42%)
     

  • BTC-AUD

    63,172.96
    -3,323.94 (-5.00%)
     

  • CMC Crypto 200

    985.61
    -1.60 (-0.16%)
     
✉️ Free sign-up:

Get the news straight to your inbox every day.

Stay in the loop every day with Yahoo Finance's free Fully Briefed newsletter.

Steve Smith takes theatrics to new level

Steve Smith may have been dismissed early in his innings, but was able to provide fans with a range of theatrical leaves. Source: Cricket Network

Latest stories

  • Egypt begins vaccine rollout to wider population

    Egypt on Thursday expanded its coronavirus vaccination rollout to include the elderly and people with chronic diseases after several weeks of vaccinating medical staff, the cabinet said. Nearly 153,000 people have applied for vaccinations since Sunday when the North African country opened online registration, the cabinet said in a statement. Egypt, the Arab world's most populous country with more than 100 million, has prepared 40 vaccination centres and plans to increase that number after the arrival of more vaccine batches, Prime Minister Mostafa Madbouly said.

  • UPDATE 1-UK starts probe on Apple's alleged anti-competitive behaviour

    Britain's competition regulator said on Thursday it has opened an investigation into Apple Inc after complaints that the iPhone maker's terms and conditions for app developers are unfair and anti-competitive. The Competition and Markets Authority said the investigation will consider whether Apple has a dominant position in the distribution of apps on Apple devices in the UK. Apple charges a commission of up to 30% to developers on the value of transactions or any time a consumer buys their app.

  • Green Revolution Gets More Expensive as Copper Price Surges

    (Bloomberg) -- Look just beneath the surface of many of the technologies powering the energy transition and there’s a red metallic glint. Copper is a vital part of green infrastructure from grids to wind turbines, and a recent price surge threatens to make decarbonization more costly.Copper has roughly doubled from the lows seen a year ago and was near a nine-year high at the start of the month. Amid predictions of a new commodity supercycle kicking off, many analysts say the top hasn’t yet been reached for a metal that’s core to the green energy drive. The price weakened as much as 4.9% to $8,660 on Thursday, the most in five months.Demand from renewable power generation, battery storage, electric vehicles, charging stations and related grid infrastructure accounts for about a fifth of copper consumption, according to Citigroup Global Markets Inc. With governments aiming for aggressive net zero emission targets in the coming decades, that means more clean electricity, a shift that’s likely to be copper-intensive given the $28.7 trillion grid build out required.Part of that growth will come from the need to connect new renewable power plants with customers. That’s because it’s often cheapest to build such plants wherever the wind or sun resource is strongest, which could be in the middle of the sea or an isolated desert. But that then means a lot more cabling -- using expensive copper -- than a centralized grid needed in the past.According to forecasts from BloombergNEF, the global power grid will grow by 48 million kilometers (30 million miles) by 2050. That’s enough to wrap around the circumference of the Earth nearly 1,200 times and equates to a doubling in copper demand to 3.6 million metric tons.“Cities, electrification and copper go together,” said Sanjeet Sanghera, an analyst at BNEF in London. “Copper plays an important role.”The metal is heavily used in underground cabling because of its conductivity, which is almost twice that of aluminum. That lowers the amount of energy needed to produce electricity.A 240-kilometer electricity interconnector between Britain and France called IFA2 used 9,000 tons of copper, according to the U.K.’s National Grid Plc. A planned link to Denmark of 760 kilometers will require 26,000 tons.In offshore wind projects, copper is still a relatively small component of costs, but that’s set to increase in the coming years, to about 3% by 2050 from 1% currently, according to BNEF.Vestas Wind Systems A/S estimates that a 100-megawatt wind farm using 4.2 megawatt turbines would use around 89 tons of copper in the turbines. If copper’s rally proves long-lasting and pushes up the cost of green investment, some wind farms may use cheaper aluminum where they can. Prices have risen less sharply compared with copper. Demand for aluminum in power grid infrastructure is estimated to reach 7.6 million metric tons by 2050, according to BNEF.“We see copper remaining integral for interconnectors,” said Srinivas Siripurapu, chief innovation officer at cable manufacturer Prysmian SpA. “But for offshore wind farms, there’s a lot of indications that there will be a push more towards aluminum driven by overall costs.”It’s not yet clear how much of an immediate impact copper’s price increase will have on the finances of green power operators. Turbine maker Siemens Gamesa Renewable Energy SA hedges raw materials prices a year ahead, protecting them for now.The metal’s rally has been driven in large part by investors who see demand soaring as the green revolution gathers pace. But their early optimism may end up pushing up costs for governments as they start putting infrastructure spending packages to work.Higher copper consumption for decarbonization could drive annual demand growth of as much as 3%, said Max Layton, managing director for Commodities Research at Citigroup Global Markets Inc. That will add to periods where supplies fall short, with upside potential for prices.While elevated prices mean companies have an incentive to ramp up investment in mining, which would help supplies, the downside is the length of time it takes to get projects up and running.“If this price level holds, we should see announcements of new projects coming in the market,” Raul Jacob, chief financial officer of Southern Copper Corp., said in an interview Monday. But the lags from decision to production will make the price cycle “a little bit longer than in the past.”(Updates with Thursday price move in second paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Platts Says Sorry to Oil Traders for Sudden Brent Overhaul

    (Bloomberg) -- S&P Global Platts apologized to oil traders for the speed at which it announced an overhaul of a price that underpins a swath of the world’s crude oil transactions.The company said the plans, which among other things involve adding U.S. crude to the key Dated Brent benchmark, took many in the market by surprise and incurred anger. Platts said it had to take the steps to ensure there’s enough oil to make up the benchmark going forward as supply from the North Sea region declines.“The suddenness of the announced changes and the lack of a further consultation have caused anger and frustration for some and we are sorry for that,” Vera Blei, head of oil markets price reporting at Platts said on a call with market participants and the media on Wednesday. “You told us that we have some work to do to rebuild relationships and trust, and that work is very much under way.”Platts first announced a consultation on the changes in December, before confirming them last week. The plan took some traders by surprise as it will involve cargoes being priced at the point of delivery -- requiring the addition of shipping costs and making other fundamental changes to what the benchmark is. The modifications matter because the Dated Brent benchmark helps price more than two-thirds of the world’s crude.Among those who had originally voiced concern about the Platts plan was Intercontinental Exchange Inc., which houses multiple contracts tied to Dated Brent.Before the revamp was announced, ICE sent Platts a letter cautioning against a speedy overhaul, according to a person familiar with the matter. The move sparked frenzied trading of some contracts last week, before both Platts and ICE issued statements clarifying their plans.ICE also said in the letter it was surprised that Platts had chosen to add U.S. crude to the benchmark, without consulting on the addition of oil from Norway’s giant Johan Sverdrup field. That crude is heavier and more sulfurous than those currently included in Dated Brent, making its addition trickier, Platts said.(Updates with Johan Sverdrup detail in final paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Indian state's hiring rule spells disaster, industry group warns

    India's northern state of Haryana, where several automakers, component suppliers and big tech firms are based, faces an investment and development disaster from a new hiring rule to tackle high unemployment, lobby groups warned on Thursday. The Federation of Indian Chambers of Commerce and Industry (FICCI) said the policy, which requires 75% of all low to mid-paying private sector jobs to go to locals, would spell disaster for Haryana's "industrial development and private investment".

  • Outlook on the Specialized Design Services Global Market to 2030 - Identify Growth Segments for Investment - ResearchAndMarkets.com

    The "Specialized Design Services Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering.

  • Outlook on the Isoflavones Global Market to 2027 - Key Drivers and Restraints

    Dublin, March 04, 2021 (GLOBE NEWSWIRE) -- The "2021 Isoflavones Market - Size, Share, COVID Impact Analysis and Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. This report provides comprehensive research with in-depth data and contemporary analysis of Isoflavones Market at a global, regional and key country level, split by different sub-segments of the industry. The report presents growth projections in the Isoflavones Market between 2021 and 2027 for companies operating across different types, applications, and end-user verticals.Isoflavones Market is quickly reaching its pre-COVID levels and a healthy growth rate is expected over the forecast period driven by the V-shaped recovery in most of the developing nations.Key strategies of companies operating in Isoflavones Market Industry are identified as showcasing their contactless manufacturing and delivery methods, highlighting USP statements, focus on product packaging, and increased the presence of products on online platforms.The food industry is set to experience a few changes in 2021 due to the increased consciousness of consumers in selecting food. This inclination towards sustainable, regenerative, plant-based food and demand for foods and beverages with immunity-boosting ingredients is driving the demand for these products and their constituents. Do It Yourself (DIY) trend has seen huge momentum during Corona times and is expected to continue in 2021.Considering the rapidly changing market landscape, companies are changing their perspectives on expanding beyond traditional markets. In addition to focusing on widening applications, introducing new product portfolios, most food and beverage companies are planning to capture domestic and international markets.Fast pace recovery of developing economies leading to increased disposable income will support the Isoflavones Market demand between 2021 and 2027.Lockdowns across the globe in 2020 and continuing restrictions in 2021 disrupted the supply chain posing challenges for manufactures in the Isoflavones Market. Intense competition, pricing issues, and shifting consumer preferences will continue to put pressure on vendors' profit margins.Short-term and long-term trends affecting the market landscape are included in the research. Further, market drivers, restraints, and potential opportunities are also provided in the report.The Isoflavones report computes the 2020 market value in revenue terms based on the average Isoflavones prices and sales/revenue models of key companies operating in the Isoflavones Market Industry. The study forecasts the market size to 2027 for different types of Isoflavones and provides respective market share and growth rates.The study discusses technological innovations and the potential shift in demand among various products in the Isoflavones Market, over the forecast period. The leading five companies in the Isoflavones Market Industry together with their products, key strategies, and comparisons are provided.The Isoflavones Market size, share, and outlook across different types and applications are provided at geographic levels of North America, Asia Pacific, Europe, Middle East Africa, South and Central America. Further, country-level Isoflavones Market value is also provided.All recent developments in Isoflavones Market Industry including mergers, acquisitions, contract awards, licenses, product launches, and expansion plans are included in the report. Base Year - 2020; Forecast period: 2021 - 2027Publication frequency - Every six monthsResearch Methodology - Data triangulation with top-down and Bottom-up approach are used for market size Scope of the Report Global Isoflavones Market Industry size, 2020-2027Market trends, drivers, restraints, and opportunitiesPorter's Five forces analysisTypes of Isoflavones, 2020-2027Isoflavones applications and end-user verticals market size, 2020-2027Isoflavones Market size across countries, 2020-20275 leading companies in the industry - overview, key strategies, financials, and productsLatest market news and developments Key Topics Covered: 1. Table of Contents2. Isoflavones Market Latest Trends, Drivers and Challenges, 2020 -20272.1 Isoflavones Market Overview2.2 Post COVID Strategies of Leading Isoflavones Companies2.3 Isoflavones Market Insights, 2021-20272.3.1 Leading Isoflavones types, 2021-20272.3.2 Leading Isoflavones End-User industries, 2021-20272.3.3 Fast-Growing countries for Isoflavones sales, 2021-20272.4 Isoflavones Market Drivers and Restraints2.4.1 Isoflavones Demand Drivers to 20272.4.2 Isoflavones Challenges to 20272.5 Isoflavones Market-Five Forces Analysis2.5.1 Isoflavones Industry Attractiveness Index, 20202.5.2 Threat of New Entrants2.5.3 Bargaining Power of Suppliers2.5.4 Bargaining Power of Buyers2.5.5 Intensity of Competitive Rivalry2.5.6 Threat of Substitutes3. Global Isoflavones Market Value, Market Share, and Forecast to 20273.1 Global Isoflavones Market Overview, 20203.2 Global Isoflavones Market Revenue and Forecast, 2021-2027 (US$ Million)3.3 Global Isoflavones Market Size and Share Outlook by Type, 2021-20273.4 Global Isoflavones Market Size and Share Outlook by End-User, 2021-20273.5 Global Isoflavones Market Size and Share Outlook by Region, 2021-20274. Asia Pacific Isoflavones Market Value, Market Share and Forecast to 20274.1 Asia Pacific Isoflavones Market Overview, 20204.2 Asia Pacific Isoflavones Market Revenue and Forecast, 2021-2027 (US$ Million)4.3 Asia Pacific Isoflavones Market Size and Share Outlook by Type, 2021-20274.4 Asia Pacific Isoflavones Market Size and Share Outlook by End-User, 2021-20274.5 Asia Pacific Isoflavones Market Size and Share Outlook by Country, 2021-20274.6 Key Companies in Asia Pacific Isoflavones Market5. Europe Isoflavones Market Value, Market Share, and Forecast to 20275.1 Europe Isoflavones Market Overview, 20205.2 Europe Isoflavones Market Revenue and Forecast, 2021-2027 (US$ Million)5.3 Europe Isoflavones Market Size and Share Outlook by Type, 2021-20275.4 Europe Isoflavones Market Size and Share Outlook by End-User, 2021-20275.5 Europe Isoflavones Market Size and Share Outlook by Country, 2021-20275.6 Key Companies in Europe Isoflavones Market6. North America Isoflavones Market Value, Market Share and Forecast to 20276.1 North America Isoflavones Market Overview, 20206.2 North America Isoflavones Market Revenue and Forecast, 2021-2027 (US$ Million)6.3 North America Isoflavones Market Size and Share Outlook by Type, 2021-20276.4 North America Isoflavones Market Size and Share Outlook by End-User, 2021-20276.5 North America Isoflavones Market Size and Share Outlook by Country, 2021-20276.6 Key Companies in North America Isoflavones Market7. South and Central America Isoflavones Market Value, Market Share and Forecast to 20277.1 South and Central America Isoflavones Market Overview, 20207.2 South and Central America Isoflavones Market Revenue and Forecast, 2021-2027 (US$ Million)7.3 South and Central America Isoflavones Market Size and Share Outlook by Type, 2021-20277.4 South and Central America Isoflavones Market Size and Share Outlook by End-User, 2021-20277.5 South and Central America Isoflavones Market Size and Share Outlook by Country, 2021-20277.6 Key Companies in South and Central America Isoflavones Market8. Middle East Africa Isoflavones Market Value, Market Share and Forecast to 20278.1 Middle East Africa Isoflavones Market Overview, 20208.2 Middle East and Africa Isoflavones Market Revenue and Forecast, 2021-2027 (US$ Million)8.3 Middle East Africa Isoflavones Market Size and Share Outlook by Type, 2021-20278.4 Middle East Africa Isoflavones Market Size and Share Outlook by End-User, 2021-20278.5 Middle East Africa Isoflavones Market Size and Share Outlook by Country, 2021-20278.6 Key Companies in Middle East Africa Isoflavones Market9. Isoflavones Market Structure9.1 Key Players 9.2 Isoflavones Companies - Key Strategies and Financial Analysis9.2.1 Snapshot9.2.2 Business Description9.2.3 Products and Services9.2.4 Financial Analysis10. Isoflavones Industry Recent Developments11 Appendix11.1 Publisher Expertise11.2 Research Methodology11.3 Annual Subscription Plans11.4 Contact InformationFor more information about this report visit https://www.researchandmarkets.com/r/tydr0k CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Liverpool’s Champions League last-16 second leg with Leipzig moved from Anfield to Budapest

    Uefa has confirmed the switch of venue

  • UPDATE 1-Western powers scrap plan for IAEA rebuke of Iran, diplomats say

    Britain, France and Germany have scrapped a U.S.-backed plan for the U.N. nuclear watchdog's board to criticise Iran for scaling back cooperation with the agency, diplomats said on Thursday, amid concerns about efforts to revive Iran's nuclear deal. The European powers, all parties to the 2015 nuclear deal, have been lobbying for the International Atomic Energy Agency's 35-nation Board of Governors to adopt a resolution at this week's quarterly meeting expressing concern at Iran's latest breaches of the deal and calling on it to undo them. However, Iran has bristled at the prospect, threatening to end a recent agreement with the IAEA that limits the impact of its latest moves and enables monitoring of its facilities to continue in a black-box-type arrangement for up to three months.

  • HSBC BANK PLC - Form 8.5 (EPT/RI) - TalkTalk Telecom Group plc

    FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree TalkTalk Telecom Group plc (c) Name of the party to the offer with which exempt principal trader is connected: Offeree - TalkTalk Telecom Group plc (d) Date dealing undertaken: 03 March 2021 (e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A” N/A 2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security Purchases/ sales Total number of securities Highest price per unit paid/received (GBP) Lowest price per unit paid/received (GBP) Ordinary Shares Purchase 1,321 96.850 p 96.850 p (b) Cash-settled derivative transactions Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit (GBP) Ordinary Shares Swap Increasing a Short Position 275 96.858 p Ordinary Shares Swap Increasing a Short Position 1,046 96.858 p (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 3. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none” Date of disclosure: 04 March 2021 Contact name: Mohammed Abdul Qader Telephone number: 0207 088 2000 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

  • Should You Buy SPACs After Their Crash?

    Privately held companies love bull markets, and with stock markets near all-time highs, it's been a great time for those private businesses to come public. Rather than going through the traditional initial public offering (IPO) process, which can be painful and long, many companies have chosen instead to come public using a special purpose acquisition company (SPAC). High-profile SPAC wins got investors truly excited about the prospects for investing in the next big disruptive company before anyone else got a chance.

  • Powerball draw 1294: The numbers you need to win $20m jackpot

    The winning Powerball numbers are in for the massive $20 million draw, so be sure to check your tickets to see if you're now a millionaire.

  • EU sets itself jobs, training and equality targets for 2030

    The European Commission on Thursday announced goals for the 27-nation bloc to reduce poverty, inequality and boost training and jobs by 2030 as part of a post-pandemic economic overhaul financed by jointly borrowed funds. The goals, which will have to be endorsed by EU leaders, also include an increase in the number of adults getting training every year to adapt to the EU's transition to a greener and more digitalised economy to 60% from 40% now. Finally, over the next 10 years, the EU should reduce the number of people at risk of poverty or social exclusion by 15 million from 91 million in 2019.

  • Philippine leader's journalist critic takes stand to deny tax fraud

    An outspoken journalist and critic of Philippine leader Rodrigo Duterte was in court on Thursday to deny dodging taxes as authorities continue a crackdown against the country's independent media.

  • Outlook on the Isolates and Concentrates Oryzenin Global Market to 2027 - Key Trends, Drivers, Restraints and Opportunities

    Dublin, March 04, 2021 (GLOBE NEWSWIRE) -- The "2021 Isolates and Concentrates Oryzenin Market - Size, Share, COVID Impact Analysis and Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. This report provides comprehensive research with in-depth data and contemporary analysis of Isolates and Concentrates Oryzenin Market at a global, regional and key country level, split by different sub-segments of the industry. This report presents growth projections in the Isolates and Concentrates Oryzenin Market between 2021 and 2027 for companies operating across different types, applications, and end-user verticals.Isolates and Concentrates Oryzenin Market is quickly reaching its pre-COVID levels and a healthy growth rate is expected over the forecast period driven by the V-shaped recovery in most of the developing nations.Key strategies of companies operating in Isolates and Concentrates Oryzenin Market Industry are identified as showcasing their contactless manufacturing and delivery methods, highlighting USP statements, focus on product packaging, and increased the presence of products on online platforms.The food industry is set to experience a few changes in 2021 due to the increased consciousness of consumers in selecting food. This inclination towards sustainable, regenerative, plant-based food and demand for foods and beverages with immunity-boosting ingredients is driving the demand for these products and their constituents. Do It Yourself (DIY) trend has seen huge momentum during Corona times and is expected to continue in 2021.Considering the rapidly changing market landscape, companies are changing their perspectives on expanding beyond traditional markets. In addition to focusing on widening applications, introducing new product portfolios, most food and beverage companies are planning to capture domestic and international markets.Fast pace recovery of developing economies leading to increased disposable income will support the Isolates and Concentrates Oryzenin Market demand between 2021 and 2027.Lockdowns across the globe in 2020 and continuing restrictions in 2021 disrupted the supply chain posing challenges for manufactures in the Isolates and Concentrates Oryzenin Market. Intense competition, pricing issues, and shifting consumer preferences will continue to put pressure on vendors' profit margins.Short-term and long-term trends affecting the market landscape are included in the research. Further, market drivers, restraints, and potential opportunities are also provided in the report.The Isolates and Concentrates Oryzenin report computes the 2020 market value in revenue terms based on the average Isolates and Concentrates Oryzenin prices and sales/revenue models of key companies operating in the Isolates and Concentrates Oryzenin Market Industry. The study forecasts the market size to 2027 for different types of Isolates and Concentrates Oryzenin and provides respective market share and growth rates.The study discusses technological innovations and the potential shift in demand among various products in the Isolates and Concentrates Oryzenin Market, over the forecast period. The leading five companies in the Isolates and Concentrates Oryzenin Market Industry together with their products, key strategies, and comparisons are provided.The Isolates and Concentrates Oryzenin Market size, share, and outlook across different types and applications are provided at geographic levels of North America, Asia Pacific, Europe, Middle East Africa, South and Central America. Further, country-level Isolates and Concentrates Oryzenin Market value is also provided.All recent developments in Isolates and Concentrates Oryzenin Market Industry including mergers, acquisitions, contract awards, licenses, product launches, and expansion plans are included in the report. Base Year - 2020; Forecast period: 2021 - 2027Publication frequency - Every six monthsResearch Methodology - Data triangulation with top-down and Bottom-up approach are used for market size Scope of the Report Global Isolates and Concentrates Oryzenin Market Industry size, 2020-2027Market trends, drivers, restraints, and opportunitiesPorter's Five forces analysisTypes of Isolates and Concentrates Oryzenin, 2020-2027Isolates and Concentrates Oryzenin applications and end-user verticals market size, 2020-2027Isolates and Concentrates Oryzenin Market size across countries, 2020-20275 leading companies in the industry - overview, key strategies, financials, and productsLatest market news and developments Key Topics Covered: 1. Table of Contents2. Isolates and Concentrates Oryzenin Market Latest Trends, Drivers and Challenges, 2020 -20272.1 Isolates and Concentrates Oryzenin Market Overview2.2 Post COVID Strategies of Leading Isolates and Concentrates Oryzenin Companies2.3 Isolates and Concentrates Oryzenin Market Insights, 2021-20272.3.1 Leading Isolates and Concentrates Oryzenin types, 2021-20272.3.2 Leading Isolates and Concentrates Oryzenin End-User industries, 2021-20272.3.3 Fast-Growing countries for Isolates and Concentrates Oryzenin sales, 2021-20272.4 Isolates and Concentrates Oryzenin Market Drivers and Restraints2.4.1 Isolates and Concentrates Oryzenin Demand Drivers to 20272.4.2 Isolates and Concentrates Oryzenin Challenges to 20272.5 Isolates and Concentrates Oryzenin Market-Five Forces Analysis2.5.1 Isolates and Concentrates Oryzenin Industry Attractiveness Index, 20202.5.2 Threat of New Entrants2.5.3 Bargaining Power of Suppliers2.5.4 Bargaining Power of Buyers2.5.5 Intensity of Competitive Rivalry2.5.6 Threat of Substitutes3. Global Isolates and Concentrates Oryzenin Market Value, Market Share, and Forecast to 20273.1 Global Isolates and Concentrates Oryzenin Market Overview, 20203.2 Global Isolates and Concentrates Oryzenin Market Revenue and Forecast, 2021-2027 (US$ Million)3.3 Global Isolates and Concentrates Oryzenin Market Size and Share Outlook by Type, 2021-20273.4 Global Isolates and Concentrates Oryzenin Market Size and Share Outlook by End-User, 2021-20273.5 Global Isolates and Concentrates Oryzenin Market Size and Share Outlook by Region, 2021-20274. Asia Pacific Isolates and Concentrates Oryzenin Market Value, Market Share and Forecast to 20274.1 Asia Pacific Isolates and Concentrates Oryzenin Market Overview, 20204.2 Asia Pacific Isolates and Concentrates Oryzenin Market Revenue and Forecast, 2021-2027 (US$ Million)4.3 Asia Pacific Isolates and Concentrates Oryzenin Market Size and Share Outlook by Type, 2021-20274.4 Asia Pacific Isolates and Concentrates Oryzenin Market Size and Share Outlook by End-User, 2021-20274.5 Asia Pacific Isolates and Concentrates Oryzenin Market Size and Share Outlook by Country, 2021-20274.6 Key Companies in Asia Pacific Isolates and Concentrates Oryzenin Market5. Europe Isolates and Concentrates Oryzenin Market Value, Market Share, and Forecast to 20275.1 Europe Isolates and Concentrates Oryzenin Market Overview, 20205.2 Europe Isolates and Concentrates Oryzenin Market Revenue and Forecast, 2021-2027 (US$ Million)5.3 Europe Isolates and Concentrates Oryzenin Market Size and Share Outlook by Type, 2021-20275.4 Europe Isolates and Concentrates Oryzenin Market Size and Share Outlook by End-User, 2021-20275.5 Europe Isolates and Concentrates Oryzenin Market Size and Share Outlook by Country, 2021-20275.6 Key Companies in Europe Isolates and Concentrates Oryzenin Market6. North America Isolates and Concentrates Oryzenin Market Value, Market Share and Forecast to 20276.1 North America Isolates and Concentrates Oryzenin Market Overview, 20206.2 North America Isolates and Concentrates Oryzenin Market Revenue and Forecast, 2021-2027 (US$ Million)6.3 North America Isolates and Concentrates Oryzenin Market Size and Share Outlook by Type, 2021-20276.4 North America Isolates and Concentrates Oryzenin Market Size and Share Outlook by End-User, 2021-20276.5 North America Isolates and Concentrates Oryzenin Market Size and Share Outlook by Country, 2021-20276.6 Key Companies in North America Isolates and Concentrates Oryzenin Market7. South and Central America Isolates and Concentrates Oryzenin Market Value, Market Share and Forecast to 20277.1 South and Central America Isolates and Concentrates Oryzenin Market Overview, 20207.2 South and Central America Isolates and Concentrates Oryzenin Market Revenue and Forecast, 2021-2027 (US$ Million)7.3 South and Central America Isolates and Concentrates Oryzenin Market Size and Share Outlook by Type, 2021-20277.4 South and Central America Isolates and Concentrates Oryzenin Market Size and Share Outlook by End-User, 2021-20277.5 South and Central America Isolates and Concentrates Oryzenin Market Size and Share Outlook by Country, 2021-20277.6 Key Companies in South and Central America Isolates and Concentrates Oryzenin Market8. Middle East Africa Isolates and Concentrates Oryzenin Market Value, Market Share and Forecast to 20278.1 Middle East Africa Isolates and Concentrates Oryzenin Market Overview, 20208.2 Middle East and Africa Isolates and Concentrates Oryzenin Market Revenue and Forecast, 2021-2027 (US$ Million)8.3 Middle East Africa Isolates and Concentrates Oryzenin Market Size and Share Outlook by Type, 2021-20278.4 Middle East Africa Isolates and Concentrates Oryzenin Market Size and Share Outlook by End-User, 2021-20278.5 Middle East Africa Isolates and Concentrates Oryzenin Market Size and Share Outlook by Country, 2021-20278.6 Key Companies in Middle East Africa Isolates and Concentrates Oryzenin Market9. Isolates and Concentrates Oryzenin Market Structure9.1 Key Players 9.2 Isolates and Concentrates Oryzenin Companies - Key Strategies and Financial Analysis9.2.1 Snapshot9.2.2 Business Description9.2.3 Products and Services9.2.4 Financial Analysis10. Isolates and Concentrates Oryzenin Industry Recent Developments11 Appendix11.1 Publisher Expertise11.2 Research Methodology11.3 Annual Subscription Plans11.4 Contact InformationFor more information about this report visit https://www.researchandmarkets.com/r/b4uvn1 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Driver arrested after car ripped in half in horrifying crash

    A man has been arrested after allegedly fleeing the scene of an accident that saw a sedan torn in half.

  • Microsoft gives Windows 10 Insiders a redesigned news feed

    Microsoft's Windows 10 Insider Preview Build 21327 includes a new-look news and interests feed complete with a redesigned browser layout and new emoji graphics.

  • Immunoglobulin Market to Exhibit CAGR of 7.0% and Hit USD 18,378.0 Million by 2025; Rising Awareness Regarding Immunoglobulins to Boost Market, states Fortune Business Insights™

    Immunoglobulin Market Key Players Studied In this Report are Shire (Takeda Pharmaceutical Company Limited), CSL Behring, Grifols, S.A., Kedrion S.p.A, Octapharma, Bio Products Laboratory Ltd., Biotest AG, China Biologic Products Holdings, Inc., LFB SA, Shanghai RAAS Blood Products Co., Ltd.Pune, India, March 04, 2021 (GLOBE NEWSWIRE) -- According to the report, Immunoglobulin market size is projected reach USD 18,378.0 Million by 2025. Global Immunoglobulin market was USD 10,750.0 million in 2018 and is anticipated to exhibit a CAGR of 7.0% during the forecast period set between 2019 to 2025. R The increasing diagnosis rates owing to escalating awareness regarding the treatment of immunoglobulins will have a tremendous effect on the market during the forecast period. The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic. Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immunoglobulins-market-100571 Introduction of Advanced Therapeutic to Augment Growth The launch of novel advanced drugs such as CUVITRU and BIVIGAM by Shire (Takeda Pharmaceutical Company Limited) and ADMA Biologics Inc., respectively will impel manufactures to innovative drugs and give competition to the rival companies, which, in turn, will spur opportunities for the market. The increasing adoption of immunoglobulin therapy as the first line of treatment for the primary immunodeficiency and other rare immunological and neurological diseases will be a critical factor in promoting the growth of the market. The growing focus on the diagnosis of immune disorders will foster the healthy growth of the market. The increasing prevalence of numerous viruses and diseases has led to pre-diagnosis, which, in turn, will augur well for the market. The growing efficiency of immunoglobulin as an effective treatment option for several diseases such as primary immunodeficiency and chronic inflammatory demyelinating polyneuropathy (CIDP) will positively enable speedy expansion of the market in the foreseeable future. Click here to get the short-term and long-term impacts of COVID-19 on this Market: https://www.fortunebusinessinsights.com/industry-reports/immunoglobulins-market-100571 The market in North America generated a revenue of US$ 6,291.5 Mn in 2017 and is and is predicted to remain dominant during the forecast period. The growth in the region is attributed to the acceptance of immunoglobulin as a first line of treatment for many critical immune disorders. Rising Patient Population to Aid Expansion in North America The increasing number of patients and the growing demand for novel therapies will further aid the growth of the market in the region. Asia Pacific is predicted to hold the largest share in the market owing to the demand for intravenous (IV) in the developing nations. The increasing healthcare expenditure and rising investment for advanced immunoglobulins will further enable growth in the region. The Middle and Africa is likely to expand in the forthcoming years owing to the developing healthcare infrastructure in the region. Quick Buy - Immunoglobulin Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100571 Key Players: Shire (Takeda Pharmaceutical Company Limited)CSL BehringGrifols, S.A.Kedrion S.p.AOctapharmaBio Products Laboratory Ltd.Biotest AGChina Biologic Products Holdings, Inc.LFB SAShanghai RAAS Blood Products Co., Ltd. Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/immunoglobulins-market-100571 Global Immunoglobulin Market Segmentations: By Route of Administration Intravenous (IV Subcutaneous (SC)) By Indication Primary ImmunodeficiencyChronic Inflammatory Demyelinating Polyneuropathy (CIDP)Guillain-Barre Syndrome (GBS)Immune Thrombocytopenic Purpura (ITP)Multifocal Motor Neuropathy (MMN)) By Form: LiquiLyophilized By End User HospitalsClinicsHomecare By Geography North America (U.S. and Canada)Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)Latin America (Brazil, Mexico, and Rest of Latin America)Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa) Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/immunoglobulins-market-100571 Have a Look at Related Reports: Kidney Stone Management Market Size, Share & COVID-19 Impact Analysis, By Type (Lithotripsy, Ureteroscopy, and Percutaneous Nephrolithonomy (PCNL) By End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and Regional Forecast, 2020-2027 Dental Materials Market Size, Share & COVID-19 Impact Analysis, By Type (Metallic Biomaterials, Ceramic Biomaterials, Polymers, Natural Biomaterials, and Others), By Application (Implant, Prosthetics, and Orthodontics), By End User (Dental Product Manufacturers, Dental Laboratories, and Others), and Regional Forecast, 2020-2027 Intensive Care Unit (ICU) Equipment Market Size, Share and Covid-19 Impact Analysis, By Product (Beds, Ventilators, Pulse Oximeters, Dialysis Equipment, and Others), By Patient (Adult and Pediatric), By Application (Neurology, Cardiology, Respiratory, Renal, Oncology, Trauma, and Others), By End-User (Hospitals, Specialty Clinics, and Others) and Regional Forecast, 2020-2027 Bone Graft Substitutes Market Size, Share & COVID-19 Impact Analysis, By Type (Autograft, Allograft, Demineralized Bone Matrix (DBM), Synthetic, and Xenograft), By Application (Spinal Fusion, Joint Reconstruction, Foot & Ankle, and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2020-2027 Cystic Fibrosis Market Size, Share & Covid-19 Impact Analysis, By Drug Class (Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), Bronchodilators, Mucolytic, Pancreatic Enzyme Supplement, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Retail Pharmacies & Drug Stores, Online Pharmacies, and Hospital Pharmacies), and Regional Forecast, 2020-2027 About Us: Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges. Contact Us: Fortune Business Insights™ Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India.Phone:US :+1 424 253 0390UK : +44 2071 939123APAC : +91 744 740 1245Email: sales@fortunebusinessinsights.comFortune Business Insights™LinkedIn | Twitter | Blogs

  • Curfew and market closures for Nigerian town of kidnapped girls

    Authorities in Nigeria's Zamfara state have declared a curfew and shut market activities after violence marred the return of hundreds of kidnapped schoolgirls to their families, a state spokesman said on Thursday. Zamfara state spokesman Sulaiman Tunau Anka called it "unfortunate civil disobedience" and said the governor had imposed a dusk-to-dawn curfew in the town, Jangebe, to prevent a further breach of the peace. Anka also said market activities would be suspended until further notice, as authorities had uncovered "strong evidence" that these activities had aided and abetted bandits.

  • Liverpool are right not to release players for international duty - and they won’t be alone

    The November break led to a spike in positive Covid cases, and the 10-day mandatory quarantine period from red list countries is a further headache clubs don’t want to contend with